Oncolytics Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.About ONCY
Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
CEOJared Kelly
CEOJared Kelly
Employees28
Employees28
HeadquartersCalgary, Alberta
HeadquartersCalgary, Alberta
Founded1998
Founded1998
Employees28
Employees28
ONCY Key Statistics
Market cap107.77M
Market cap107.77M
Price-Earnings ratio-3.53
Price-Earnings ratio-3.53
Dividend yield—
Dividend yield—
Average volume665.52K
Average volume665.52K
High today$1.04
High today$1.04
Low today$0.9712
Low today$0.9712
Open price$0.9712
Open price$0.9712
Volume481.05K
Volume481.05K
52 Week high$1.51
52 Week high$1.51
52 Week low$0.3258
52 Week low$0.3258
Stock Snapshot
As of today, Oncolytics Biotech(ONCY) shares are valued at $0.99. The company's market cap stands at 107.77M, with a P/E ratio of -3.53.
On 2025-12-13, Oncolytics Biotech(ONCY) stock moved within a range of $0.97 to $1.04. With shares now at $0.99, the stock is trading +2.3% above its intraday low and -4.5% below the session's peak.
Trading activity shows a volume of 481.05K, compared to an average daily volume of 665.52K.
The stock's 52-week range extends from a low of $0.33 to a high of $1.51.
The stock's 52-week range extends from a low of $0.33 to a high of $1.51.
ONCY News
TipRanks 4d
Oncolytics Biotech Plans Jurisdiction Shift to NevadaTipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.